![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, July 31, 2017 9:12:40 PM
Marc Tesio is an experienced investment banker who has successfully raised in excess of $50 million of capital for life sciences and other companies. Most recently, he managed a registered direct public offering for Dara Biosciences, Inc., a life science company developing therapeutic treatments for diseases including diabetes. He also acted as financial advisor to ResverLogix, a Canadian biotechnology company that is developing two novel technologies for important global medical markets, and managed a early stage life science investment for Digene Corporation. Prior to his activities in healthcare corporate finance he managed a syndicate desk and oversaw trading and settlements serving international banks and European based institutional portfolio managers. He began his career at Oppenheimer. He holds a degree with honors in Financial Management from Old Dominion University. He serves his local community helping non-profit organizations and enjoys amateur Georgia State athletic competitions and his family in Atlanta. He holds the Series 7, 24, 63 and 79 securities licenses.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM